{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:55:23Z","timestamp":1774385723157,"version":"3.50.1"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602156"],"award-info":[{"award-number":["602156"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005280","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T18:40:26Z","timestamp":1486060826000},"page":"e1005280","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations"],"prefix":"10.1371","volume":"13","author":[{"given":"Christoph","family":"Thiel","sequence":"first","affiliation":[]},{"given":"Henrik","family":"Cordes","sequence":"additional","affiliation":[]},{"given":"Lorenzo","family":"Fabbri","sequence":"additional","affiliation":[]},{"given":"H\u00e9l\u00e8ne Eloise","family":"Aschmann","sequence":"additional","affiliation":[]},{"given":"Vanessa","family":"Baier","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1772-6487","authenticated-orcid":false,"given":"Ines","family":"Smit","sequence":"additional","affiliation":[]},{"given":"Francis","family":"Atkinson","sequence":"additional","affiliation":[]},{"given":"Lars Mathias","family":"Blank","sequence":"additional","affiliation":[]},{"given":"Lars","family":"Kuepfer","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2174\/138161205774414510","article-title":"Why drugs fail\u2014a study on side effects in new chemical entities","volume":"11","author":"D Schuster","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"Suppl 2","key":"ref2","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1086\/381446","article-title":"Drug-induced liver injury","volume":"38","author":"N Kaplowitz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure","volume":"376","author":"W Bernal","year":"2010","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJM199312163292508","article-title":"Acute Liver Failure","volume":"329","author":"WM Lee","year":"1993","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199510263331706","article-title":"Drug-Induced Hepatotoxicity","volume":"333","author":"WM Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thx.50.2.213","article-title":"Hepatotoxicity caused by the combined action of isoniazid and rifampicin","volume":"50","author":"DS Askgaard","year":"1995","journal-title":"Thorax"},{"key":"ref7","first-page":"213","article-title":"Enhancement of cyclosporine A nephrotoxicity by diclofenac","volume":"27","author":"G Deray","year":"1987","journal-title":"Clin Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"J Chen","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0300-483X(85)90159-3","article-title":"Increased hepatotoxicity of acetaminophen by concomitant administration of caffeine in the rat","volume":"34","author":"C Sato","year":"1985","journal-title":"Toxicology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1158\/1078-0432.CCR-03-0785","article-title":"Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development","volume":"10","author":"JW Park","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/egh.10.8","article-title":"Biomarkers for drug-induced liver injury","volume":"4","author":"Q Shi","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CBF.S27900","article-title":"Biomarkers of drug-induced liver injury","volume":"13","author":"K Wang","year":"2013","journal-title":"Curr Biomark Find"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2012.08.012","article-title":"Transcriptional biomarkers\u2013High throughput screening, quantitative verification, and bioinformatical validation methods","volume":"59","author":"I Riedmaier","year":"2013","journal-title":"Methods"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/pgs.10.184","article-title":"Transcriptional profiling to identify biomarkers of disease and drug response","volume":"12","author":"DL Mendrick","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9929.1000119","article-title":"Using microRNA as Biomarkers of Drug-Induced Liver Injury","volume":"2","author":"WF Salminen","year":"2011","journal-title":"J Mol Biomark Diagn"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jprot.2012.11.022","article-title":"Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress","volume":"79","author":"A Wilmes","year":"2013","journal-title":"J Proteomics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/msb.2013.20","article-title":"Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding","volume":"9","author":"M Iskar","year":"2013","journal-title":"Mol Syst Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00204-015-1536-3","article-title":"Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-\u03baB activation and sensitizes toward TNF\u03b1-induced cytotoxicity","volume":"90","author":"B Herpers","year":"2015","journal-title":"Arch Toxicol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/tpj.2013.39","article-title":"Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity","volume":"14","author":"JD Zhang","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"ref20","article-title":"Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients","author":"C Thielc","year":"2016","journal-title":"Arch Toxicol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"D921","DOI":"10.1093\/nar\/gku955","article-title":"Open TG-GATEs: a large-scale toxicogenomics database","volume":"43","author":"Y Igarashi","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/dmd.111.043174","article-title":"Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling","volume":"40","author":"M Meyer","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"DS Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/ci300046g","article-title":"<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/chemicalize.org\" xlink:type=\"simple\">chemicalize.org<\/ext-link> <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/chemicalize.org\" xlink:type=\"simple\">chemicalize.org<\/ext-link> by ChemAxon Ltd","volume":"52","author":"M Swain","year":"2012","journal-title":"J Chem Inf Model"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15563650801941831","article-title":"Acetaminophen protein adducts: A review","volume":"47","author":"GR Bond","year":"2009","journal-title":"Clin Toxicol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1124\/jpet.106.108993","article-title":"Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives","volume":"319","author":"KM Waldhauser","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2125.1988.tb05311.x","article-title":"Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method","volume":"26","author":"ME Veronese","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"R Latini","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/419194","article-title":"The Determination of Partition Coefficient of 6-Mercaptopurine Derivatives by Thin Layer Chromatography","volume":"2013","author":"A Czyrski","year":"2013","journal-title":"J Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro","volume":"66","author":"BP Mahoney","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0731-7085(03)00377-7","article-title":"Relation between retention factors of immunosuppressive drugs in microemulsion electrokinetic chromatography with biosurfactants and octanol-water partition coefficients","volume":"33","author":"SE Lucangioli","year":"2003","journal-title":"J Pharm Biomed Anal"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007691-198810010-00004","article-title":"A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients","volume":"10","author":"B Legg","year":"1988","journal-title":"Ther Drug Monit"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","article-title":"Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls","volume":"33","author":"NM Davies","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jps.2600650641","article-title":"Remington\u2019s pharmaceutical sciences","volume":"65","author":"A. Osol","year":"1976","journal-title":"J Pharm Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2125.1999.00831.x","article-title":"Pharmacokinetics of flutamide in patients with renal insufficiency","volume":"47","author":"Swan Anjum","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the Human Metabolome Database","volume":"35","author":"DS Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2125.1982.tb01981.x","article-title":"Plasma protein binding of phenytoin in 100 epileptic patients","volume":"14","author":"GM Peterson","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2165\/00003088-197803020-00002","article-title":"Clinical pharmacokinetics of rifampicin","volume":"3","author":"G Acocella","year":"1978","journal-title":"Clin Pharmacokinet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1358\/mf.2003.25.6.769652","article-title":"Clinical pharmacokinetics of statins","volume":"25","author":"MJ Garc\u00eda","year":"2003","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/psp.2012.14","article-title":"A Mechanistic, Model-Based Approach to Safety Assessment in Clinical Development","volume":"1","author":"J Lippert","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF00645133","article-title":"Disposition of valproic acid in man","volume":"12","author":"R Gugler","year":"1977","journal-title":"Eur J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jps.24214","article-title":"A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation","volume":"104","author":"C Thiel","year":"2015","journal-title":"J Pharm Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","article-title":"The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development","volume":"102","author":"LZ Benet","year":"2013","journal-title":"J Pharm Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-291X(03)00871-4","article-title":"Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins","volume":"305","author":"Y Shi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrc2248","article-title":"The impact of a negligent G2\/M checkpoint on genomic instability and cancer induction","volume":"7","author":"M L\u00f6brich","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature03097","article-title":"Cell-cycle checkpoints and cancer","volume":"432","author":"MB Kastan","year":"2004","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/bies.950170603","article-title":"Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle","volume":"17","author":"EA Nigg","year":"1995","journal-title":"Bioessays"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-3565(24)37925-X","article-title":"Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity","volume":"288","author":"R Bort","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0773.1990.tb00840.x","article-title":"Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor)","volume":"67","author":"Y Horsmans","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.1840090504","article-title":"Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients","volume":"9","author":"JH Lewis","year":"1989","journal-title":"Hepatology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"MJ Waring","year":"2010","journal-title":"Expert Opin Drug Discov"},{"key":"ref52","article-title":"Encyclopedia of Psychopharmacology","author":"IP Stolerman","year":"2010"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"PY Muller","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/08860229909045192","article-title":"Acute effects of acetaminophen on renal function and urinary excretion of some proteins and enzymes in patients with kidney disease","volume":"21","author":"M Miti\u0107-Zlatkovi\u0107","year":"1999","journal-title":"Ren Fail"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1824-7288-37-17","article-title":"Acute interstitial nephritis with acetaminophen and alcohol intoxication","volume":"37","author":"LL Fruchter","year":"2011","journal-title":"Ital J Pediatr"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.3892\/or.2013.2747","article-title":"Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis","volume":"30","author":"BR Han","year":"2013","journal-title":"Oncol Rep"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1756-9966-29-149","article-title":"Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line","volume":"29","author":"Y Yagi","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/bmb\/ldl020","article-title":"Thiopurines, DNA damage, DNA repair and therapy-related cancer","volume":"79\u201380","author":"P Karran","year":"2006","journal-title":"Br Med Bull"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.141.3.531","article-title":"The effect of azathioprine (Imuran\u00c2) on the cell cycle of promonocytes and the production of monocytes in the bone marrow","volume":"141","author":"R van Furth","year":"1975","journal-title":"J Exp Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1478-5382(03)02342-4","article-title":"PK-Sim: a physiologically based pharmacokinetic \u201cwhole-body\u201d model","volume":"1","author":"S Willmann","year":"2003","journal-title":"Biosilico"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied Concepts in PBPK Modeling: How to Build a PBPK\/PD Model","volume":"5","author":"L Kuepfer","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"T Rodgers","year":"2006","journal-title":"J Pharm Sci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jps.20322","article-title":"Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases","volume":"94","author":"T Rodgers","year":"2005","journal-title":"J Pharm Sci"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tiv.2007.09.010","article-title":"General approach for the calculation of tissue to plasma partition coefficients","volume":"22","author":"W Schmitt","year":"2008","journal-title":"Toxicol Vitr"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/17425255.1.1.159","article-title":"From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools","volume":"1","author":"S Willmann","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/jps.2600630804","article-title":"Determination of isoniazid and metabolites in biological fluids","volume":"63","author":"HG Boxenbaum","year":"1974","journal-title":"J Pharm Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1515\/DMDI.2011.016","article-title":"Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects","volume":"26","author":"C Bing","year":"2011","journal-title":"Drug Metabol Drug Interact"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0090-9556(25)06540-7","article-title":"Human liver cytochrome P4503A biotransformation of the cyclosporin derivative SDZ IMM 125","volume":"23","author":"AE Vickers","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1152\/physrev.1994.74.1.163","article-title":"Transport of macromolecules across microvascular walls: the two-pore theory","volume":"74","author":"B Rippe","year":"1994","journal-title":"Physiol Rev"},{"key":"ref70","unstructured":"FDA. Food and Drug Administration. Drugs@FDA <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/050207s064lbl.pdf\" xlink:type=\"simple\">https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/050207s064lbl.pdf<\/ext-link> [Accessed 18 March 2016]. 2016;"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF00548589","article-title":"Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites","volume":"19","author":"FD Juma","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2125.1979.tb01004.x","article-title":"Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration","volume":"8","author":"FD Juma","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.39.1.63","article-title":"Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration","volume":"39","author":"EC Van Os","year":"1996","journal-title":"Gut"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e1002998","DOI":"10.1371\/journal.pcbi.1002998","article-title":"Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network","volume":"9","author":"J Huang","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/msb.2010.70","article-title":"Towards whole-body systems physiology","volume":"6","author":"L Kuepfer","year":"2010","journal-title":"Mol Syst Biol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap","volume":"43","author":"T Metsalu","year":"2015","journal-title":"Nucleic Acids Res"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T23:25:14Z","timestamp":1749943514000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005280"}},"subtitle":[],"editor":[{"given":"Donna K.","family":"Slonim","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005280","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}